Results 251 to 260 of about 4,758,008 (341)

Exploring the role of intelectin-1 in modulating asthma through the gut-bone-lung axis. [PDF]

Gut Microbes
He S, Hu X, Gong X, Cheng Q, Zhu S, Chen Y, Luo Y, Wang Y, Zhu G, Wan T, Chen C, Li H, Pan P, Xie H, Wang Z.   +14 more
europepmc   +1 more source

Inflammation and cancer

Nature, 2002
L. Coussens, Z. Werb
semanticscholar   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source

More Evidence of the Health Risks from Being Skinny Fat: The Association with Systemic Inflammation [PDF]

Rachel Liu‐Galvin, Frank A. Orlando, Aaron Saguil, Ara Jo, Kristy Smith, Andrew C. Miller, Elizabeth Sanders, David E. Nelson, Arch G. Mainous   +8 more
openalex   +1 more source

Phospholipase Cε promotes intestinal tumorigenesis of Apc Min/+ mice through augmentation of inflammation and angiogenesis [PDF]

, 2009
Mingzhen Li, Hironori Edamatsu, Riko Kitazawa, Sohei Kitazawa, Tohru Kataoka   +4 more
openalex   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Diagnostic value of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and systemic immune-inflammation index for predicting the severity of acute pancreatitis [PDF]

Amir Mohammad Salehi, Ramin Rezaei, Atefeh Sadeghi, Erfan Ayubi, Maryam Hasanzarrini, Ahmad Rezaee Azandaryani, Mehta Razzaghi   +6 more
openalex   +1 more source

The lncRNA Malat1 functions as a ceRNA to contribute to berberine-mediated inhibition of HMGB1 by sponging miR-181c-5p in poststroke inflammation [PDF]

, 2019
Ding-wen Cao, Manman Liu, Rui Duan, Yifu Tao, Junshan Zhou, Weirong Fang, Junrong Zhu, Li Niu, Jianguo Sun   +8 more
openalex   +1 more source

Adipose immune microenvironment: catalyst of age-related adipose tissue dysfunction. [PDF]

Immun Ageing
Song Y, Xing H, Luo Y, Li B, Li Y, Dong Z.   +5 more
europepmc   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source